Aequs IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Dec 03 2025
The Aequs IPO GMP is ₹46 as of 3rd December 2025. It is a bookbuilding IPO of ₹921.81 crores. This is an entirely fresh issue of 5.40 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 10th December 2025. The face value of Aequs IPO shares is ₹1 per share, and the IPO price band is ₹118 to ₹124 per share. Retail investors can bid for a minimum of 1 lot of 135 shares worth ₹14,985.
Aequs IPO GMP Grey Market Premium
As mentioned earlier, the Aequs IPO GMP currently stands at ₹46.5 per share. Thus, the estimated listing price would be flat at ₹170.5. This indicates that the estimated listing gain in this IPO could be 37.50%. Explore the table for the Aequs IPO GMP updates.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 3-12-2025 | ₹124.00 | ₹46.50 | ₹170.50 | 37.50% |
| 2-12-2025 | ₹124.00 | ₹46.50 | ₹170.50 | 37.50% |
| 1-12-2025 | ₹124.00 | ₹44.50 | ₹168.50 | 35.89% |
| 30-11-2025 | ₹124.00 | ₹43.50 | ₹167.50 | 35.08% |
| 29-11-225 | ₹124.00 | ₹43.00 | ₹167.00 | 34.68% |
| 28-11-2025 | ₹124.00 | ₹40.00 | ₹164.00 | 32.26% |
Note: GMP details are subject to change based on market conditions and fluctuations. Check live Aequs IPO GMP status here<https://univest.in/ipo/neochem-bio-ipo>
Aequs IPO Details
| IPO Allotment Date | 8th December 2025 |
| IPO Open Date | 3rd December 2025 |
| IPO Close Date | 5th December 2025 |
| Refund Initiation | 9th December 2025 |
| Issue Size | 7,43,39,651 shares(aggregating up to ₹921.81 Cr) |
| Fresh Issue | 5,40,32,258 shares(aggregating up to ₹670.00 Cr) |
| Offer for Sale | 2,03,07,393 shares of ₹10(aggregating up to ₹251.81 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 120 Shares |
| Issue Price | ₹118 to ₹124 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | 10th December 2025 |
Also Read: Aequs IPO GMP & Review: Apply or Avoid?
Explanation
Aequs IPO: Aequs IPO Limited has declared an issue price band of ₹118.00 to ₹124.00 per share. With this IPO, the company allows retail investors to bid for at least one lot of 120 shares, each worth ₹14,880. The face value of Aequs IPO Limited shares is ₹10 per share. The shares of Aequs IPO Limited will be listed on BSE and SME on its tentative listing day, 10th December 2025. Scroll down to check GMP updates and Aequs IPO reviews.
Aequs IPO Objectives
The primary objective of the Aequs IPO is to raise ₹921.81 crore. However, before applying for the IPO, it is essential to understand its secondary objectives. Explore them below
- Repayment and/ or prepayment, in whole or in part, of certain outstanding borrowings and prepayment penalties, as applicable,
- The Company
- three of the wholly-owned Subsidiaries, through investment in the following Subsidiaries
- AeroStructures Manufacturing India Private Limited
- Aequs Consumer Products Private Limited
- Aequs Engineered Plastics Private Limited
- Funding capital expenditure to be incurred on account of the purchase of machinery and equipment by the company
- Funding capital expenditure to be incurred on account of the purchase of machinery and equipment by one of the wholly-owned Subsidiaries, AeroStructures Manufacturing India Private Limited, through investment in such Subsidiary
- Funding inorganic growth through unidentified acquisitions, other strategic initiatives and general corporate purposes
Aequs IPO Registrar
According to recent updates, Kfin Technologies Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Aequs allotment and refund, you can contact Kfin Technologies Limited at aequs.ipo@kfintech.com 04067162222, 04079611000.
Aequs IPO Review
The Aequs IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Aequs Limited’s revenue decreased by 3% from ₹988.30 crore in March 2024 to ₹959.21 crore in March 2025. Moreover, the company’s PAT decreased by 619% from -₹14.24 crores to -₹102.35 crores.
Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Aequs IPO or not.
Aequs IPO Technicals
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | -74.71 |
| EPS (Earnings Per Share) | -1.66 |
| RoNW | -14.47 |
| ROCE | 0.87 |
| ROE | -14.30 |
| EBITDA Margin | 11.68% |
| Price to Book Value | 9.94 |
| Market Capitalisation | ₹8,316.06 |
The P/E ratio of Aequs Limited’s shares is -74.71, and its Earnings Per Share (EPS) is -1.66. Thus, the Aequs Limited IPO can deliver gains on its tentative listing day, 10th December 2025
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Aequs Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | -74.71 | -244.92 |
| EPS | -1.66 | -0.51 |
FAQs on Aequs IPO
What is the Aequs IPO GMP?
Currently, on 3rd December 2025, the Aequs IPO GMP (Grey Market Premium) stands at ₹46.50. This indicates that the estimated listing price could be ₹170.50 per share.
What is the issue price of Aequs IPO?
The Aequs IPO price range is ₹118.00 to ₹124.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 120 shares, worth ₹14,880. Moreover, HNIs are required to bid for a minimum of 14 lots (1,680 shares) worth ₹2,08,320.
Who is the registrar of Aequs IPO?
Kfin Technologies Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Aequs IPO GMP, allotment, and refund, you can contact Kfin Technologies Limited at aequs.ipo@kfintech.com or 04067162222, 04079611000.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Aequs IPO, download the Aequs IPO RHP and Aequs IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Ravelcare IPO GMP: Day 3 IPO Live Updates
Astron Multigrain IPO Subscription Day 2
Astron Multigrain IPO GMP: Day 2 IPO Live Updates
Invicta Diagnostic IPO Subscription Day 2
